Scout | PAR-25-070: Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

grant PAR-25-070

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Summary

This grant opportunity aims to support research on incretin mimetics, which are known for their impact on thyroid, prostate, and other cancer risks, as well as having a more favorable balance of effectiveness and side effects compared to other similar treatments. Additionally, the grant encourages scientists to explore the effects of incretin mimetics on diseases beyond cancer.

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically glucagon-like peptide ( GLP)-1 or dual GLP-1/ glucose-dependent insulinotropic polypepide …

Funding Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Awards & funding

Award Ceiling: $200,000

Eligibility

Higher Education Institutions — Private Institutions of Higher Education

Nonprofits (Other than Institutions of Higher Education) — without 501(c)(3) IRS Status

For-Profit Organizations — Other than Small Businesses

Federal Government — Eligible Agencies of the Federal Government

U.S. Territory or Possession

Independent School Districts

Public Housing Authorities/Indian Housing Authorities

Native American Tribal Organizations (other than Federally recognized tribal governments)

Faith-based or Community-based Organizations

Regional Organizations

Non-domestic (non-U.S.) Entities (Foreign Organizations)

Non-domestic (non-U.S.) components of U.S. Organizations

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Required registrations (must be completed before submission; can take 6+ weeks; failure to register is not a valid reason for late submission): • System for Award Management (SAM) — active registration…

Dates

Opportunity Released: November 18, 2024

Open for Submission: November 18, 2024

Submission Deadline: January 7, 2027

Application Window Closes: January 7, 2027

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers